1. Evaluation of Food and Spherical Carbon Adsorbent Effects on the Pharmacokinetics of Roxadustat in Healthy Nonelderly Adult Male Japanese Subjects. Issue 3 (2nd July 2018) Authors: Shibata, Tomohisa; Nomura, Yuki; Takada, Akitsugu; Ueno, Mai; Katashima, Masataka; Yazawa, Rie; Furihata, Kenichi Journal: Clinical pharmacology in drug development Issue: Volume 8:Issue 3(2019) Page Start: 304 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Intermittent Oral Dosing of Roxadustat in Peritoneal Dialysis Chronic Kidney Disease Patients with Anemia: A Randomized, Phase 3, Multicenter, Open‐Label Study. Issue 2 (31st July 2019) Authors: Akizawa, Tadao; Otsuka, Tetsuro; Reusch, Michael; Ueno, Mai Journal: Therapeutic apheresis and dialysis Issue: Volume 24:Issue 2(2020) Page Start: 115 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Multiple imputation for longitudinal data in the presence of heteroscedasticity between treatment groups. Issue 1 (2nd January 2020) Authors: Yamaguchi, Yusuke; Ueno, Mai; Maruo, Kazushi; Gosho, Masahiko Journal: Journal of biopharmaceutical statistics Issue: Volume 30:Issue 1(2020) Page Start: 178 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Oral roxadustat three times weekly in ESA‐naïve and ESA‐converted patients with anemia of chronic kidney disease on hemodialysis: Results from two phase 3 studies. Issue 6 (5th February 2020) Authors: Akizawa, Tadao; Ueno, Mai; Shiga, Takanori; Reusch, Michael Journal: Therapeutic apheresis and dialysis Issue: Volume 24:Issue 6(2020) Page Start: 628 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗